Kidney diseases, particularly Acute Kidney Injury (AKI) and Chronic Kidney
Disease (CKD), are identified as global public health issues affecting millions of individuals.
In addition, the frequency of renal diseases in the population has increased dramatically
and rapidly in recent years. Renal disorders have become a significant public
health burden. The pathophysiology of renal diseases is significantly connected with renal
cell death, including apoptosis, necrosis, necroptosis, ferroptosis, pyroptosis, and autophagy,
as is now recognized. Unlike other forms of cell death, pyroptosis is a unique
planned cell death (PCD). Scientists have proven that pyroptosis is crucial in developing
various disorders, and this phenomenon is gaining increasing attention. It is considered a
novel method of inflammatory cell death. Intriguingly, inflammation is among the most
significant pathological characteristics of renal disease. This study investigates the effects
of pyroptosis on Acute Kidney Injury (AKI), Chronic Kidney Disease (CKD), Diabetic
Nephropathy (DN), Immunoglobulin A (IgA) Nephropathy, and Lupus Nephritis
(LN) to identify novel therapeutic targets for kidney diseases.